Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammation and vascular calcification.

Sharon M Moe1, Neal X Chen

  • 1Indiana University and Roudebush Veterans Affairs Medical Center, Indianapolis, IN 46260, USA. smoe@iupui.edu

Blood Purification
|January 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age-related differences in the skeletal phenotype of Brown Norway rats induced to develop chronic kidney disease.

Bone·2026
Same author

Semaglutide, at a dose that produces modest weight loss, induces mild suppression of bone remodeling in healthy control rats and those with chronic kidney disease.

Bone·2026
Same author

Radiomics identifies distinct cortical bone texture alterations in patients with CKD using HR-pQCT.

Bone research·2026
Same author

Determining Physical Function Measures for Estimating VO<sub>2</sub>Peak in Patients Receiving Hemodialysis.

Kidney medicine·2026
Same author

A Metabolomics Approach To Identify Metabolites Associated with Uremic Symptoms in Patients Receiving Maintenance Hemodialysis.

Kidney360·2025
Same author

Diffusion tractography of kidney by high angular resolution diffusion imaging.

Magnetic resonance letters·2025
Same journal

Peritoneal Glucose Uptake Reduction by Sodium-Glucose Co-Transporter 2 Inhibitors in Clinical Peritoneal Dialysis.

Blood purification·2026
Same journal

With the Generalization of AI and Algorithms, Will We Still Need a Nephrologist in the Dialysis Room?

Blood purification·2026
Same journal

Could serum CA125 aid the clinical assessment of volume status of end-stage kidney disease patients treated by peritoneal dialysis patients?

Blood purification·2026
Same journal

From Bench to Bedside: Implications and Interventions for Endotoxin Exposure in Lipopolysaccharide-Induced Apoptosis and Eryptosis.

Blood purification·2026
Same journal

Feasibility Study of a Smartphone App and Web Portal for Remote Monitoring of Chronic Kidney Disease and Peritoneal Dialysis populations: A mixed-method study.

Blood purification·2026
Same journal

Treatment of Focal Segmental Glomerulosclerosis in Low- and Middle-Income Countries: Emerging Extracorporeal Therapies.

Blood purification·2026
See all related articles

Chronic kidney disease (CKD) patients experience significant vascular calcification and inflammation, increasing morbidity and mortality. Inflammation accelerates calcification by reducing protective fetuin-A levels in CKD patients.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Pathology

Background:

  • Vascular calcification and inflammation are prevalent in chronic kidney disease (CKD).
  • CKD patients, especially those on dialysis, exhibit higher rates of coronary and peripheral artery calcification than the general population.
  • Both intimal and medial vascular calcification in CKD are linked to increased morbidity and mortality.

Purpose of the Study:

  • To explore the mechanisms linking inflammation and vascular calcification in chronic kidney disease.
  • To understand how uremic serum induces vascular smooth muscle cell transformation into osteoblast-like cells.
  • To investigate the role of inflammatory mediators and fetuin-A in CKD-related vascular calcification.

Main Methods:

  • Review of existing literature on vascular calcification and inflammation in CKD.

Related Experiment Videos

  • Analysis of the cellular processes involved in vascular calcification.
  • Examination of the impact of uremic serum and inflammatory mediators on vascular cells.

    • Main Results:

    • Vascular calcification in CKD is an active, cell-mediated process involving vascular smooth muscle cell transformation.
    • Inflammatory mediators like oxidation, carbonyl stress, C-reactive protein, and cytokines may directly promote vascular calcification.
    • Inflammation reduces fetuin-A, a key inhibitor of vascular calcification, exacerbating mineral deposition.

    Conclusions:

    • The uremic environment in CKD promotes vascular calcification through accelerated processes and impaired defense mechanisms.
    • Inflammation plays a critical role in driving vascular calcification in CKD by both direct stimulation and reduction of inhibitors.
    • Understanding these mechanisms is crucial for managing cardiovascular complications in CKD patients.